L309-1392 Screening compound: 4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-6-(morpholine-4-sulfonyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one

L309-1392 Screening compound: 4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-6-(morpholine-4-sulfonyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one
L309-1392 Screening compound: 4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-6-(morpholine-4-sulfonyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one alternative view

Chemical Structure Depiction of ChemDiv screening compound L309-1392
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-6-(morpholine-4-sulfonyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L309-1392

Molecular Formula

C19H22N4O6S (C19 H22 N4 O6 S)

Compound Name

4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-6-(morpholine-4-sulfonyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one

IUPAC name

4-[(5-cyclobutyl-124-oxadiazol-3-yl)methyl]-6-(morpholine-4-sulfonyl)-34-dihydro-2H-14-benzoxazin-3-one

SMILES

O=C1N(Cc2noc(C3CCC3)n2)c(cc(cc2)S(N3CCOCC3)(=O)=O)c2OC1

InChI

InChI=1S/C19H22N4O6S/c24-18-12-28-16-5-4-14(30(25,26)22-6-8-27-9-7-22)10-15(16)23(18)11-17-20-19(29-21-17)13-2-1-3-13/h4-5,10,13H,1-3,6-9,11-12H2

InChI Key

ZMBNTIHVDNQEMX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27244211

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

434.47

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.328

Distribution Coefficient, logD

1.328

Water Solubility, LogSw

-2.46

Polar Surface Area

96.879

Acid Dissociation Constant (pKa)

20.50

Base Dissociation Constant (pKb)

-3.76

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.60

L309-1392 in Drug Discovery

Included in Screening Libraries

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Epigenetic
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others

References: we are preparing a list of scientific research reports with L309-1392 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L309-1392?
Check Price and Availability of L309-1392, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L309-1392 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L309-1392
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L309-1392
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L309-1392 available by request